19-05-22-EuroPCR2019-main-live-11-42-17_

AWARD FOR INNOVATION IN CARDIOLOGY

Recognizing Groundbreaking Contributions in the Field

The Jon DeHaan Foundation provides funding to individuals and companies focused on commercializing innovative developments in cardiovascular medicine.

MAKING A DIFFERENCE

Award Recipients

VahatiCor

"We are thrilled to be recipients of this prestigious award - it's a huge bonus for VahatiCor !"

Dr. Rishi Puri,
Mark Niggli, CEO,
Marwan Berrada-Sounni, Co-Founder

Paragate Medical

"In the dynamic world of startups, countless "no's" form the backdrop. Yet, sometimes, a single resounding "yes" reverberates—a beacon of hope and validation.

On behalf of the entire Paragate Medical team, we extend heartfelt gratitude to the John De-Hann Foundation. This recognition and award carry immense weight—a testament to our commitment and mission: shifting heart failure care toward home-based solutions.

With renewed vigor, we embrace the path ahead, fueled by such affirmative moment."

Nitai Hanani
CEO

Magneto Thrombectomy Solutions

"The Magneto team extends sincere gratitude to the Jon Dehaan Foundation for this prestigious recognition. This acknowledgment not only validates our endeavors but also serves as a reminder of the high standards we uphold in everything we do. It reflects the innovative spirit and excellence that define our company culture. As we celebrate this remarkable accomplishment, we remain resolute in our mission to surpass expectations and bring positive transformations to both patients and healthcare professionals. This award acts as an inspiration to persist in our pursuit of excellence and to push the boundaries of innovation and success."

Benny Dilmoney
CEO

Alchimedics

"On behalf of AlchiMedics, it is with profound gratitude that we address our sincerest thanks to the Jon DeHaan Foundation for honoring us with this prestigious award at the ICI2024 conference. This recognition not only validates our dedication and innovative approach to enhancing patient safety through our groundbreaking CD31 coating technology but also significantly elevates our visibility within the global medical community. This award serves as a catalyst, propelling AlchiMedics further in our mission to drastically reduce or even eliminate the need for anti-platelet therapies following cardiology and neurology interventions, thus improving the quality of life for millions of patients worldwide. "

Christopher Bureau, PhD.
President

HeartPoint Global

“We are deeply honored to have been named CRF’s TCT 2023 Shark Tank Innovation Competition winner. HeartPoint Global’s groundbreaking method for treating Pulmonary Arterial Hypertension resulting from congenital heart disease (PAH-CHD) holds promise for addressing a substantial clinical gap. The HeartPoint Global team sincerely thanks the Jon Dehaan Foundation for this esteemed honor. This acknowledgment, validation, and support propel us forward in our mission to make advanced cardiac care accessible and affordable for all.”

Seth Bogner
CEO

Rob Taft

"It was an honor to win the Best Innovation Award at EuroPCR Innovation Day this year. We are excited to bring the PHx Rivet Shunt forward as a novel treatment option for underserved patients with heart failure and pulmonary hypertension. We are deeply grateful to the Jon DeHaan Foundation for sponsoring this award, which will help us further our early clinical studies evaluating the impact of a right-to-right shunt."

Rob Taft
NXT Biomedical, LLC.

Append Medical

"Congratulations to Append Medical and CEO, Nadav Agian, for winning Silver in the ICI Meeting 2022 Innovation Award Startup Competition. The Jon DeHaan Foundation is pleased to be able to sponsor this company!"

Dr. Robert Schwartz
President
Jon DeHaan Foundation

Acorai AB

"The ICI Innovation Award is an incredible recognition of the hard work of the Acorai team and the ground-breaking nature of the Acorai Heart Monitor. We're honored and humbled to accept this prize which has led to improved awareness of our solution and many collaborations with hospitals around the world."

Filip Peters
CEO

Dr. Michael Miedema

"I am very honored to receive this award from the Jon DeHaan Center for Medical Innovation. At the Nolan Family Center for Cardiovascular Health at the Minneapolis Heart Institute Foundation, we are trying to improve cardiovascular health through research, education, and leadership and this award provides validation of those efforts. It is greatly appreciated."

Puzzle Medical Devices, Inc.

"It is an honor to be recognized by CRF and the Jon DeHaan Foundation. Our team is grateful to have been chosen from the other innovative companies that presented at this year’s TCT Shark Tank Innovation Competition. With the successful completion of our first in-human study, further investigations are underway using the ModulHeart device."

Jade Doucet-Martineau
Co-Founder & CEO

Pulse Medical

"We are very grateful for the Jon DeHaan Foundation, not only for the grant itself, but also for the recognition of our work. With this grant, we will be able to carry out more international validation studies on the use of angiography-based coronary physiology and biomechanics, thus accelerating the global adoption of our novel technologies. "

Shengxian Tu
Professor of Shanghai Jiao Tong University &
Co-Founder of Pulse Medical

Photo Credit - © EuroPCR 2022 all rights reserved

Donisi Health

"Donisi Health is honored to have won the 2021 ICI Innovation Competition and the Jon DeHaan Foundation's Award for Innovation in Cardiology. Donisi is focused on developing solutions for chronic patients at home, with a goal to reduce readmission rates for CHF patients- and others. We greatly appreciate the opportunity to highlight our breakthrough technology’s potential to meaningfully improve cardiovascular health. Thank you for this recognition of our team’s diligent work and affirmation of Donisi’s path to bringing a truly disruptive health-tech innovation solution to market.”

Yair Brosh
CEO

AquaPass

"We are truly honored to be recognized as the most promising early-stage innovation company in the TCT 2021 Shark Tank. At AquaPass, we aim to change the lives of millions of patients around the world who are suffering from fluid overload caused by heart failure and other underlying diseases. On behalf of the entire AquaPass team, we would like to thank The Jon DeHaan Foundation for this prestigious award. The recognition and support received from the Foundation will bring us another step closer to achieving our vision."

Erez Hybloom, CEO
Yaacov Nitzan, Founder & CTO

Lungpacer Medical

"On behalf of myself and the Lungpacer medical team we would like to express our deep appreciation for being selected as the winner of the Jon DeHaan Foundation's Award for Innovation in Cardiology at the 2021 TCT Conference. This recognition will further support the development of Lungpacer's transvascular neurostimulation therapy, which is designed to empower natural independent breathing and improve the quality of life for people dependent on artificial ventilation. The Jon DeHaan Foundation has a rich history of providing crucial support for early-stage transformative medical therapies such as ours. In that spirit, we are pleased to pay forward the financial component of this award to the second-place team at AquaPass to multiply the impact of this prestigious recognition and further foster medical innovation."

Doug Evans
President & CEO

Alio

"We are so humbled and honored to receive this award from the Jon DeHaan Foundation. We consider this recognition as further proof that there is still so much more that can be done to improve the lives of those faced with chronic conditions. We are committed to bringing our vision to life by enabling better care through enhanced insights. We truly appreciate the support and recognition we received from the Foundation."

David Kuraguntla
CEO & Founder

Fondazione Policlinico A. Gemelli IRCCS

"We are so honored to receive this prestigious award from the Jon DeHaan Foundation. All our efforts are devoted to improving the quality of life of people affected by heart failure, always remembering that the development and success of each innovation are based on the passion, collaboration, and dedication of all the professionals involved and on the commitment and the engagement of our patients. We deeply appreciate the support and recognition received from the Foundation."

Dr. Domenico D'Amario

Autus Valve Technologies

"This wonderful initiative offers crucial support for early stage cardiovascular devices such as ours. We thank the Jon DeHaan Foundation for their tremendous support and commitment to fostering cardiac innovation."

Dr. Sophie-Charlotte Hofferberth
Co-Founder & President

VDyne

"On behalf of the team at VDyne, Inc. we would like to thank the Jon DeHaan Foundation for their generous support of the ICI Innovation Competition. Winning this award is recognition by the medical community of the potential our VDyne Transcatheter Tricuspid Valve Replacement System has to address a largely unmet need in their patients. It recognizes the many hours the team has invested to develop the novel design and delivery approach. Most important, this support will further our efforts to make this device available to patients suffering from tricuspid regurgitation."

Robert Vidlund, COO
David Pomfret, RPh, Sr. Director Clinical Affairs

On Sight Medical

"The On Sight team truly appreciates the outstanding generosity and support we received form Mr. DeHaan and the Foundation. This grant enables On Sight to bring ultrasound capabilities to the novice user, which results in improved patient care, particularly in rural areas, underserved populations, and developing countries. It is making a significant impact on the screening, analysis, monitoring, and diagnosis of cardiac disease."

Dr. Achi Ludomirsky, MD
Co-Founder & CMO

Healium Medical

"On behalf of myself and the Healium Medical team we would like to express our deep appreciation for being selected winner of the Jon DeHaan Foundation Award for Innovation in Cardiology at the ICI2019 conference. This prestigious award is a recognition of the importance of our journey aimed at providing improved care to patients suffering from atrial fibrillation using our advanced No-Contact Guided Ultrasound Ablation technology. Using this outstanding award we intend to continue and accelerate the development of our ultrasound technology with the strong hope and vision to offer improved outcomes to atrial fibrillation patients undergoing catheter ablation procedures."

Ran Sela
CEO

FilterLex

"It has been a great honor for Filterlex and myself to receive the Jon DeHaan Foundation Award for Innovation in Cardiology.
We appreciate the recognition of the importance to protect the brain and the rest of the body during TAVR procedure. Filterlex carries the vision of procedural safety and the mission to deliver it in an easy and successful way. Although we are a start-up company, we see the patients in front of us, and aim to provide them with the best care.
With the generous Jon DeHaan Foundation grant, we will be able to further develop and soon to bring to patients a mature and improved device to protect them. We are now getting ready for the first-in-human experience, and thanks to your grant we will be able to move forward with these plans."

Dr. Giora Weisz
Founder & Chairman of Advisory Board

Dr. Jonathon Leipsic

"We intended to build on our past work delving into the mechanisms of bioprosthetic valve failure. Our data suggests that the mechanisms and timelines of valve degeneration are consistent across surgical and transcatheter bioprosthetic heart valves and a better understanding of structural valve degeneration can be obtained through combining further histological and novel imaging approaches. We will continue along this path of investigation through the generous support of the DeHaan Foundation Award which will allow us perform the needed advanced analyses to help advance our understanding of this complex process so that we can hopefully develop potential solutions to this important clinical problem."

InterVene

"On behalf of our entire company, Fletcher and I wanted thank Mr. DeHaan personally for his support for the Shark Tank Competition and the innovation it recognizes, and we’ll reflect on this often as one of the high-points in the life of InterVene."

Jeff Elkins, COO
Fletcher Wilson, Founder & CEO

Aria CV

"We are honored to name Aria CV as this year’s TCT Shark Tank Competition Winner for their innovative technology in pulmonary hypertension," said Juan F. Granada, MD, President and Chief Executive Officer of the Cardiovascular Research Foundation, the sponsor of TCT. “It’s a truly novel concept with potential to improve the survival and quality of life for people with heart disease.”

Dr. Kelly Han

"I truly appreciate this opportunity and [Mr. DeHaan’s] incredible generosity. One person can make a difference. With this grant, Mr. DeHaan is making a very large difference in cardiac care.”

AWARD FOR INNOVATION IN CARDIOLOGY

MAKING A DIFFERENCE

CONTACT JON DEHAAN FOUNDATION